Most Active Stories
- Why Teacher Pay Matters Even If You Are Not a Teacher [Interactive Map]
- Sixth-Grader's Science Fair Finding Shocks Ecologists
- NC Archaeologist Has Find-Of-A-Lifetime, 3 Years In A Row
- Carl Kasell Helps With Surprise Marriage Proposal
- Police In NC Could Start Tracking License Plates On State Highways
Hosts, Reporters and Producers
Mon April 1, 2013
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 8:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.